Alnylam Pharmaceuticals (ALNY) Gross Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 526.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -5.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -165.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21,616.00 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,616.00 |
| Dec 31, 2025 | -710.00 |
| Sep 30, 2025 | 58.00 |
| Jun 30, 2025 | -816.00 |
| Mar 31, 2025 | -22,290.00 |
| Dec 31, 2024 | -94.00 |
| Sep 30, 2024 | -578.00 |
| Jun 30, 2024 | 1,344.00 |
| Mar 31, 2024 | 193.00 |
| Dec 31, 2023 | -259.00 |
| Sep 30, 2023 | 322.00 |
| Jun 30, 2023 | -849.00 |
| Mar 31, 2023 | -198.00 |
| Dec 31, 2022 | -77.00 |
| Sep 30, 2022 | 116.00 |
| Jun 30, 2022 | -142.00 |
| Mar 31, 2022 | 197.00 |
| Dec 31, 2021 | 31.00 |
| Sep 30, 2021 | 158.00 |
| Jun 30, 2021 | 385.00 |
| Mar 31, 2021 | 41.00 |
| Dec 31, 2020 | 366.00 |
| Sep 30, 2020 | -911.00 |
| Jun 30, 2020 | -789.00 |
| Mar 31, 2020 | -332.00 |
| Dec 31, 2019 | -907.00 |
| Sep 30, 2019 | -82.00 |